Back to Search Start Over

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).

Authors :
Rebecca Hein
Melanie Maranian
John L Hopper
Miroslaw K Kapuscinski
Melissa C Southey
Daniel J Park
Marjanka K Schmidt
Annegien Broeks
Frans B L Hogervorst
H Bas Bueno-de-Mesquita
Kenneth R Muir
Artitaya Lophatananon
Suthee Rattanamongkongul
Puttisak Puttawibul
Peter A Fasching
Alexander Hein
Arif B Ekici
Matthias W Beckmann
Olivia Fletcher
Nichola Johnson
Isabel dos Santos Silva
Julian Peto
Elinor Sawyer
Ian Tomlinson
Michael Kerin
Nicola Miller
Frederick Marmee
Andreas Schneeweiss
Christof Sohn
Barbara Burwinkel
Pascal Guénel
Emilie Cordina-Duverger
Florence Menegaux
Thérèse Truong
Stig E Bojesen
Børge G Nordestgaard
Henrik Flyger
Roger L Milne
Jose Ignacio Arias Perez
M Pilar Zamora
Javier Benítez
Hoda Anton-Culver
Argyrios Ziogas
Leslie Bernstein
Christina A Clarke
Hermann Brenner
Heiko Müller
Volker Arndt
Christa Stegmaier
Nazneen Rahman
Sheila Seal
Clare Turnbull
Anthony Renwick
Alfons Meindl
Sarah Schott
Claus R Bartram
Rita K Schmutzler
Hiltrud Brauch
Ute Hamann
Yon-Dschun Ko
GENICA Network
Shan Wang-Gohrke
Thilo Dörk
Peter Schürmann
Johann H Karstens
Peter Hillemanns
Heli Nevanlinna
Tuomas Heikkinen
Kristiina Aittomäki
Carl Blomqvist
Natalia V Bogdanova
Iosif V Zalutsky
Natalia N Antonenkova
Marina Bermisheva
Darya Prokovieva
Albina Farahtdinova
Elza Khusnutdinova
Annika Lindblom
Sara Margolin
Arto Mannermaa
Vesa Kataja
Veli-Matti Kosma
Jaana Hartikainen
Xiaoqing Chen
Jonathan Beesley
Kconfab Investigators
AOCS Group
Diether Lambrechts
Hui Zhao
Patrick Neven
Hans Wildiers
Stefan Nickels
Dieter Flesch-Janys
Paolo Radice
Paolo Peterlongo
Siranoush Manoukian
Monica Barile
Fergus J Couch
Janet E Olson
Xianshu Wang
Zachary Fredericksen
Graham G Giles
Laura Baglietto
Catriona A McLean
Gianluca Severi
Kenneth Offit
Mark Robson
Mia M Gaudet
Joseph Vijai
Grethe Grenaker Alnæs
Vessela Kristensen
Anne-Lise Børresen-Dale
Esther M John
Alexander Miron
Robert Winqvist
Katri Pylkäs
Arja Jukkola-Vuorinen
Mervi Grip
Irene L Andrulis
Julia A Knight
Gord Glendon
Anna Marie Mulligan
Jonine D Figueroa
Montserrat García-Closas
Jolanta Lissowska
Mark E Sherman
Maartje Hooning
John W M Martens
Caroline Seynaeve
Margriet Collée
Per Hall
Keith Humpreys
Kamila Czene
Jianjun Liu
Angela Cox
Ian W Brock
Simon S Cross
Malcolm W R Reed
Shahana Ahmed
Maya Ghoussaini
Paul D P Pharoah
Daehee Kang
Keun-Young Yoo
Dong-Young Noh
Anna Jakubowska
Katarzyna Jaworska
Katarzyna Durda
Elżbieta Złowocka
Suleeporn Sangrajrang
Valerie Gaborieau
Paul Brennan
James McKay
Chen-Yang Shen
Jyh-Cherng Yu
Huan-Ming Hsu
Ming-Feng Hou
Nick Orr
Minouk Schoemaker
Alan Ashworth
Anthony Swerdlow
Amy Trentham-Dietz
Polly A Newcomb
Linda Titus
Kathleen M Egan
Georgia Chenevix-Trench
Antonis C Antoniou
Manjeet K Humphreys
Jonathan Morrison
Jenny Chang-Claude
Douglas F Easton
Alison M Dunning
Source :
PLoS ONE, Vol 7, Iss 8, p e42380 (2012)
Publication Year :
2012
Publisher :
Public Library of Science (PLoS), 2012.

Abstract

The 6q25.1 locus was first identified via a genome-wide association study (GWAS) in Chinese women and marked by single nucleotide polymorphism (SNP) rs2046210, approximately 180 Kb upstream of ESR1. There have been conflicting reports about the association of this locus with breast cancer in Europeans, and a GWAS in Europeans identified a different SNP, tagged here by rs12662670. We examined the associations of both SNPs in up to 61,689 cases and 58,822 controls from forty-four studies collaborating in the Breast Cancer Association Consortium, of which four studies were of Asian and 39 of European descent. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Case-only analyses were used to compare SNP effects in Estrogen Receptor positive (ER+) versus negative (ER-) tumours. Models including both SNPs were fitted to investigate whether the SNP effects were independent. Both SNPs are significantly associated with breast cancer risk in both ethnic groups. Per-allele ORs are higher in Asian than in European studies [rs2046210: OR (A/G) = 1.36 (95% CI 1.26-1.48), p = 7.6 × 10(-14) in Asians and 1.09 (95% CI 1.07-1.11), p = 6.8 × 10(-18) in Europeans. rs12662670: OR (G/T) = 1.29 (95% CI 1.19-1.41), p = 1.2 × 10(-9) in Asians and 1.12 (95% CI 1.08-1.17), p = 3.8 × 10(-9) in Europeans]. SNP rs2046210 is associated with a significantly greater risk of ER- than ER+ tumours in Europeans [OR (ER-) = 1.20 (95% CI 1.15-1.25), p = 1.8 × 10(-17) versus OR (ER+) = 1.07 (95% CI 1.04-1.1), p = 1.3 × 10(-7), p(heterogeneity) = 5.1 × 10(-6)]. In these Asian studies, by contrast, there is no clear evidence of a differential association by tumour receptor status. Each SNP is associated with risk after adjustment for the other SNP. These results suggest the presence of two variants at 6q25.1 each independently associated with breast cancer risk in Asians and in Europeans. Of these two, the one tagged by rs2046210 is associated with a greater risk of ER- tumours.

Subjects

Subjects :
Medicine
Science

Details

Language :
English
ISSN :
19326203
Volume :
7
Issue :
8
Database :
Directory of Open Access Journals
Journal :
PLoS ONE
Publication Type :
Academic Journal
Accession number :
edsdoj.bcfd88daf90c42a397f31d12f9e2759f
Document Type :
article
Full Text :
https://doi.org/10.1371/journal.pone.0042380